Interní Med. 2010; 12(4): 178-180

New antidiabetic drugs in the treatment of type 2 diabetes mellitus

MUDr.Martina Lášticová, doc.MUDr.Alena Šmahelová, Ph.D.
Klinika gerontologická a metabolická LF UK a FN Hradec Králové

Therapeutical approach to type 2 diabetes has changed over last years. Non-pharmacological intervention, dietary and lifestyle modification,

remain mainstay of therapy. At the same time, it is usually necessary to start pharmacological treatment. There are new antidiabetic

drug classes targeting different pathogenetic mechanisms, that allow us to individualize therapy to specific needs of a patient

with type 2 diabetes.

Keywords: type 2 diabetes mellitus, thiazolidinediones, incretin mimetics, gliptins, insulin analogues

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lášticová M, Šmahelová A. New antidiabetic drugs in the treatment of type 2 diabetes mellitus. Interní Med. 2010;12(4):178-180.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Narayan KM, et al. Lifetime risk for diabetes mellitus in the US. JAMA 2003; 290: 1884-1890. Go to original source... Go to PubMed...
    2. Pelikánová T. Inzulin. In: Škrha J, et al. Diabetologie. Praha, Galén 2009: 298-324.
    3. Svačina Š, Šmahelová A, Haluzík M. Perorální antidiabetika. In: Škrha J, et al. Diabetologie. Praha, Galén 2009: 284-298.
    4. Nathan DM, et al. Management of Hyperglycemia in Type 2 Diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2006; 49: 1711-1721. Go to original source... Go to PubMed...
    5. Nathan DM, et al. Management of Hyperglycemia in Type 2 Diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consesus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009: 32(1): 193-203. Go to original source... Go to PubMed...
    6. UKPDS 34, Effect of intensive blood-glucose control with metformin on complications in overweight patiens with type 2 diabetes. Lancet 1998; 35: 854-865.
    7. Šmahelová A. Metformin. In: Haluzík M, et al. Trendy soudobé diabetologie. Praha, Galén 2008: 61-103.
    8. Nesto RW, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation 2003; 108: 2941-2948. Go to original source... Go to PubMed...
    9. Kvapil M, et al. Konsenzus k léčbě inzulinovými analogy. Postgraduální medicína 2009; 4: 417-422.
    10. Svačina Š, Bretšnajdrová A, Šmahelová A. Dietní léčba diabetu 2. typu. In: Svačina Š, et al. Klinická dietologie. Praha, Grada Publishing 2008: 135-153.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.